On September 25, 2018 Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, reported that company management will participate in three upcoming conferences (Press release, Xencor, SEP 25, 2018, View Source [SID1234529623]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2018 Cantor Global Healthcare Conference
Date: Tuesday, October 2, 2018
Location: New York, NY
Presentation Time: 10:55 a.m. ET

Leerink Partners Roundtable Series: Rare Disease & Oncology
Date: Wednesday, October 3, 2018
Location: New York, NY
Presentation Time: 10:00 a.m. ET

BTIG Biotech Conference
Date: Thursday, October 25, 2018
Location: New York, NY
Management will be available for one-on-one meetings.
Live webcasts of both the 2018 Cantor Global Healthcare Conference and the Leerink Partners Roundtable Series: Rare Disease & Oncology presentations will be available under "Events & Presentations" in the Investors section of the Company’s website located at View Source A replay of the presentations will be posted on the Xencor website approximately one hour after the live events and will be available for 90 days following the presentations.